Latest News about SNY
Recent news which mentions SNY
Analysts Love This Newly Formed Healthcare Company; Should You?
August 16, 2021
From Motley Fool
What Rinvoq's Positive News Means for AbbVie
August 13, 2021
From Motley Fool
3 Best Biotech Stocks To Buy for Upcoming Catalysts
August 12, 2021
From InvestorPlace
Europe stocks have been on a winning streak. Here are a few stock ideas from Jefferies
August 10, 2021
From MarketWatch
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
From Benzinga
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
August 05, 2021
From Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
August 05, 2021
From Benzinga
From Benzinga
How This Historic FDA Approval Benefits Viatris
August 04, 2021
From Motley Fool
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
Why Translate Bio Stock Soared Today
August 03, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
July 29, 2021
From Benzinga
Earnings Scheduled For July 29, 2021
July 29, 2021
From Benzinga
From Benzinga
7 Cheap Value Stocks to Buy for August 2021
July 27, 2021
From InvestorPlace
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
July 22, 2021
From Benzinga
From InvestorPlace
From Benzinga
5 French Stocks To Consider For Bastille Day
July 14, 2021
From Benzinga
Is This Coronavirus Stock Undervalued?
July 14, 2021
From Motley Fool